SureTrader SureTrader
Home > Boards > US Listed > Medical - Drugs >

Metabasis Therapeutics, Inc. (MBRX)

MBRX RSS Feed
Add MBRX Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 9/23/2016 12:51:06 AM - Followers: 2 - Board type: Free - Posts Today: 0
Moleculin Biotech, Inc. (Nasdaq: MBRX) to Ring The Nasdaq Stock Market Closing Bell in celebration of IPO

Metabasis Therapeutics (NASDAQ:MBRX)
Historical Stock Chart

Moleculin Biotech (Nasdaq:MBRX), a preclinical and clinical-stage pharmaceutical company focused on the development of anti-cancer drug candidates, will visit the Nasdaq MarketSite in Times Square to celebrate its initial public offering (IPO).

In honor of the occasion, Walter Klemp, Chief Executive Officer, will ring the Closing Bell.

Where:
Nasdaq MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio

When:
Thursday, June 2, 2016 – 3:45 p.m. to 4:00 p.m. ET

Moleculin Biotech Media Contact:
Sean Leous
(646) 863-8998
sleous@pcgadvisory.com
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
MBRX
Current Price
Volume:
Bid Ask Day's Range
SureTrader
MBRX News: Current Report Filing (8-k) 09/28/2016 08:32:08 AM
MBRX News: Current Report Filing (8-k) 09/23/2016 08:15:35 AM
MBRX News: Current Report Filing (8-k) 09/12/2016 05:02:05 PM
MBRX News: Current Report Filing (8-k) 08/25/2016 06:48:34 AM
MBRX News: Statement of Changes in Beneficial Ownership (4) 08/23/2016 04:48:42 PM
PostSubject
#3   And so? Big news. Loosy stock Magouille 09/23/16 12:51:06 AM
#2   NASDAQ listing $5MM equity requirement IPO$ 06/17/16 11:20:36 AM
#1   UPDATE -- Moleculin Biotech, Inc. (Nasdaq: MBRX) to IPO$ 06/17/16 11:08:33 AM
PostSubject